Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
JACI-35054 by AC Immune for Alzheimer's Disease: Likelihood of Approval
JACI-35054 is under clinical development by AC Immune and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...